Zydus Cadila gets USFDA nod for Anti-Fungal Ointment
New Delhi: Zydus Cadila said it has received final approval from the US health regulator to market Nystatin and Triamcinolone Acetonide Ointment, used in the treatment of fungal skin infections. Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/gram and 1 mg/gram, the company said in a BSE filing.
Zydus Cadila said the drug will be manufactured at the group's Topical manufacturing facility at Ahmedabad.
The group has more than 226 approvals, and so far filed over 330 abbreviated new drug applications (ANDAs) since it started filings in 2003-04.
Shares of Cadila Healthcare, the listed entity of the group, were trading 1.01 higher per cent at Rs 364 apiece on BSE.
Read Also : Zydus Cadila gets USFDA Approval for Vardenafil Hydrochloride Tablets
Zydus Cadila said the drug will be manufactured at the group's Topical manufacturing facility at Ahmedabad.
The group has more than 226 approvals, and so far filed over 330 abbreviated new drug applications (ANDAs) since it started filings in 2003-04.
Shares of Cadila Healthcare, the listed entity of the group, were trading 1.01 higher per cent at Rs 364 apiece on BSE.
Read Also : Zydus Cadila gets USFDA Approval for Vardenafil Hydrochloride Tablets
ANDAanti-fungalCadilafinal approvalHealthcareoinmenttriamcinolone acetonideUnited States Food and Drug AdministrationUS health regulatorUSFDAzydus
Source : PTIMedical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here
Next Story
NO DATA FOUND
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd